SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), including tumors smaller than one centimeter, ...

Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...

Statins lower artery-clogging cholesterol and cut risks of cardiovascular disease, heart attacks and strokes. But are the drugs helpful if you have fatty liver disease, or can they be harmful? We ...

Discover how sugar quietly damages your liver through dangerous mechanisms. Learn about fatty liver disease, inflammation, ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Cinnamon and honey before bed may support weight loss—but not magically. Here’s what science says about their true metabolic ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...